Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen

被引:44
|
作者
Sim, Adrian C. N. [1 ]
Lin, Wenwei [1 ]
Tan, Grace K. X. [1 ]
Sim, Magenta S. T. [1 ]
Chow, Vincent T. K. [2 ]
Alonso, Sylvie [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Immunol Programme, Singapore 117548, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Infect Dis Programme, Singapore 117548, Singapore
基金
英国医学研究理事会;
关键词
dengue; E domain III; Lactococcus lactis;
D O I
10.1016/j.vaccine.2007.12.047
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mucosal vaccines present several advantages over conventional parenteral vaccines including their ease of administration and Low cost, both criteria being priorities for developing countries plagued by infectious diseases. A recombinant Lactococcus lactis strain producing the envelope domain III (EDIII) antigen from dengue virus serotype 2 was engineered, and the ability of the live recombinant bacteria to trigger a systemic anti-EDIII IgG antibody response upon nasal or oral administration to BALB/c and C57BL/6 mice was investigated. Results showed that the antibody response depended on the route of administration and on the mouse strain inoculated. Out of six, two and three C57BL/6 mice orally and nasally inoculated with the recombinant bacteria, respectively, displayed anti-EDIII antibody responses higher than that obtained in the mouse group intraperitoneally (i.p.) immunized with heat-inactivated dengue 2 virus. The protective potential of the immune sera was measured using the plaque reduction neutralizing test (PRNT) and results indicated that high anti-EDIII antibody levels did not correlate directly with high neutralizing activities. Immune sera from orally inoculated mice were found the most potent to neutralize in vitro dengue infection with neutralizing antibody activities in some cases higher than that obtained with the immune sera from mice i.p. injected with heat-inactivated virus. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1145 / 1154
页数:10
相关论文
共 39 条
  • [31] The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2
    Valdes, Iris
    Gil, Lazaro
    Romero, Yaremis
    Castro, Jorge
    Puente, Pedro
    Lazo, Laura
    Marcos, Ernesto
    Guzman, Maria G.
    Guillen, Gerardo
    Hermida, Lisset
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (03) : 455 - 459
  • [32] Heterologous prime-boost vaccination with DNA vaccine and recombinant subunit containing four serotypes of dengue virus envelope protein domain III elicits neutralizing antibodies and specific T-cell responses
    Pan, Chien-Hsiung
    Hu, Hui-mei
    Hsiao, Yu-Ju
    Wu, Sze-Hsien
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [33] Vaccination with recombinant Lactococcus lactis expressing HA1-IgY Fc fusion protein provides protective mucosal immunity against H9N2 avian influenza virus in chickens
    Zhang, Ruihua
    Xu, Tong
    Li, Ziping
    Li, Longfei
    Li, Chunhong
    Li, Xinrui
    Wang, Zhiyue
    Wang, Shaohua
    Wang, Xuejing
    Zhang, Hongliang
    VIROLOGY JOURNAL, 2023, 20 (01)
  • [34] Vaccination with recombinant Lactococcus lactis expressing HA1-IgY Fc fusion protein provides protective mucosal immunity against H9N2 avian influenza virus in chickens
    Ruihua Zhang
    Tong Xu
    Ziping Li
    Longfei Li
    Chunhong Li
    Xinrui Li
    Zhiyue Wang
    Shaohua Wang
    Xuejing Wang
    Hongliang Zhang
    Virology Journal, 20
  • [35] NEUTRALIZING ANTIBODIES AGAINST HIV-1 BRU AND SF2 ISOLATES GENERATED IN MICE IMMUNIZED WITH RECOMBINANT VACCINIA VIRUS EXPRESSING HIV-1 (BRU) ENVELOPE GLYCOPROTEINS AND BOOSTED WITH HOMOLOGOUS GP160
    HU, SL
    KLANIECKI, J
    DYKERS, T
    SRIDHAR, P
    TRAVIS, BM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (07) : 615 - 620
  • [36] A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
    Ramasamy, Viswanathan
    Arora, Upasana
    Shukla, Rahul
    Poddar, Ankur
    Shanmugam, Rajgokul K.
    White, Laura J.
    Mattocks, Melissa M.
    Raut, Rajendra
    Perween, Ashiya
    Tyagi, Poornima
    de Silva, Aravinda M.
    Bhaumik, Siddhartha K.
    Kaja, Murali Krishna
    Villinger, Francois
    Ahmed, Rafi
    Johnston, Robert E.
    Swaminathan, Sathyamangalam
    Khanna, Navin
    PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (01):
  • [37] Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus
    Wenqian Wang
    Yuxin Song
    Linlin Liu
    Yuan Zhang
    Tingting Wang
    Wang Zhang
    Kai Li
    Xiaole Qi
    Yulong Gao
    Li Gao
    Changjun Liu
    Yanping Zhang
    Yongqiang Wang
    Qing Pan
    Gaoming He
    Xiaomei Wang
    Hongyu Cui
    Microbial Cell Factories, 18
  • [38] Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus
    Wang, Wenqian
    Song, Yuxin
    Liu, Linlin
    Zhang, Yuan
    Wang, Tingting
    Zhang, Wang
    Li, Kai
    Qi, Xiaole
    Gao, Yulong
    Gao, Li
    Liu, Changjun
    Zhang, Yanping
    Wang, Yongqiang
    Pan, Qing
    He, Gaoming
    Wang, Xiaomei
    Cui, Hongyu
    MICROBIAL CELL FACTORIES, 2019, 18 (1)
  • [39] Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5
    Lin, Yinling
    Kwon, Taewoo
    Polo, John
    Zhu, Yi-Fei
    Coates, Stephen
    Crawford, Kevin
    Dong, Christine
    Wininger, Mark
    Hall, John
    Selby, Mark
    Coit, Doris
    Medina-Selby, Angelica
    McCoin, Colin
    Ng, Philip
    Drane, Debbie
    Chien, David
    Han, Jang
    Vajdy, Michael
    Houghtont, Michael
    JOURNAL OF VIROLOGY, 2008, 82 (15) : 7492 - 7503